USSTOCK.TODAY
Pre-Market
Log in Sign up

AstraZeneca records $16.2 billion in Q3 revenue, maintains guidance

Proactive +6 · ·by G4L

AZN Astrazeneca plc
$186.76 -1.39%
View chart & analysis →
  1. 1AstraZeneca total revenue reached $16.2 billion in Q3 on a constant exchange rate basis, representing a 7% increase.
  2. 2AstraZeneca plans to increase its annual dividend to $3.30 per share.
  3. 3AstraZeneca completed a $2 billion investment in Summit Therapeutics.

So what's the key point?

AstraZeneca generated $16.2 billion in revenue during the third quarter. The company decided to raise its dividend and invest $2 billion in Summit Therapeutics.

Source Proactive +6 · View original ↗

Related 3-line summaries

Eli Lilly widens market cap gap with Novo Nordisk in obesity treatment competition The Motley Fool +7 · yesterdayRhythm Pharmaceuticals shares surge 28% on AstraZeneca's $10 billion acquisition proposal WSJ +2 · 6d agoAstraZeneca Q3 Core EPS Beats Consensus Earnings Whispers · 6d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news